EVRG vs PRAX · P/E 22, rev $5.96B vs $7.38B cap
Evergy, Inc. (EVRG) versus Praxis Precision Medicines Inc (PRAX) — a side-by-side from cached financials, not a winner call.
Evergy, Inc. (EVRG) is a utilities - regulated electric company listed on NASDAQ.
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
Latest reported EVRG revenue for 2025-12-31 was $5.96B. Net income was $855.6M. Revenue was up 2.0% from 2024-12-31 to 2025-12-31. EVRG currently screens at market cap $19.10B and trailing P/E 22.0.
Latest reported PRAX revenue for 2025-09-30 was $0. Net income was -$73.9M. PRAX currently screens at market cap $7.38B.
EVRG currently screens at market cap $19.10B and trailing P/E 22.0. PRAX currently screens at market cap $7.38B.
Not investment advice. Open the EVRG and PRAX stock pages for the full models.
Not investment advice.